In addition , the results for the all therapeutic effects showed identical trends to the results obtained in the original analysis , including the statistically similar effects of ETV and ETV maleate treatment-induced decreases in mean HBV DNA level at weeks @ , @ , and @ ( ETV : by @ , @ , and @ log@ IU/ml vs. ETV maleate : by @ , @ , and @ log@ IU/ml , respectively ; all vs. baseline P more than @ ) , achievement of undetectable levels of serum HBV DNA ( less than @ IU/ml ) at week @ ( ETV : @ % vs. ETV maleate : @ % ; P more than @ ) , HBeAg loss rates at week @ ( ETV : @ % vs. ETV maleate : @ % ; P more than @ ) , HBeAg seroconversion rates at week @ ( ETV : @ % vs. ETV maleate : @ % ; P more than @ ) , normalization of alanine aminotransferase at week @ ( ETV : @ % vs. ETV maleate : @ % ; P more than @ ) , and overall incidence of AE ( ETV : @ % vs. ETV maleate : @ % ; P more than @ ) .